Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Profile edited	Wed, 10/12/2022 - 13:23	Profile edited		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/event/covid-19-south-africa		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%A7%84%ED%96%89%EC%84%B1-%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91%EC%9D%98-%EC%8B%9C%EA%B8%B0%EC%A0%81%EC%A0%88%ED%95%9C-%EC%A4%91%EC%9E%AC-%EC%B9%98%EB%A3%8C		Анонимен
Newsletter opened	Tue, 08/04/2020 - 02:37	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Tue, 08/04/2020 - 00:51	Opened		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Profile edited	Wed, 10/12/2022 - 13:23	Profile edited		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/event/covid-19-south-africa		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/expert-view-page-0		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%A7%84%ED%96%89%EC%84%B1-%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91%EC%9D%98-%EC%8B%9C%EA%B8%B0%EC%A0%81%EC%A0%88%ED%95%9C-%EC%A4%91%EC%9E%AC-%EC%B9%98%EB%A3%8C		Анонимен
Newsletter opened	Tue, 08/04/2020 - 02:37	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%A7%9E%EC%B6%A4%ED%98%95-%EC%A3%BC%EC%9A%94%EC%9A%B0%EC%9A%B8%EC%9E%A5%EC%95%A0-%EC%B9%98%EB%A3%8C%EB%A5%BC-%ED%96%A5%ED%95%9C-%EB%85%B8%EB%A0%A5		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Tue, 08/04/2020 - 00:51	Opened		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER